Vaccine

Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche's Protein Play & More

9 days ago   |   By Xconomy

As the nation started to reopen this week following two months of closed businesses and stay-at-home orders, public health officials and economists cautioned that society won't truly return to anything resembling a pre-pandemic normal without a COVID-19 vaccine. Moderna moved one step closer to filling that need with the release of preliminary Phase 1 data for its messenger RNA vaccine candidate. No major safety problems were reported and there were some indications that the injections elicited antibodies. But Phase 1 clinical trials are small, and it's unknown whether those early results...
Read more ...

 


Search by Tags

   Vaccine      Vaccines      RNA      Protein      Clinical      Health      Boston blog main      Boston top stories      Boulder      Denver blog main      Denver top stories      Detroit blog main      Detroit top stories      Europe blog main      Europe top stories      Indiana blog main      Indiana top stories      National      National blog main      National top stories      New York blog main      New York top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      San Diego blog main      San Diego top stories      San Francisco blog main      San Francisco top stories      Seattle blog main      Seattle top stories      Texas blog main      Texas top stories      Wisconsin blog main      Wisconsin top stories      Alexion Pharmaceuticals      AMAG Pharmaceuticals      Amplyx Pharmaceuticals      Apomorphine      Appelis Pharmaceuticals      Applied Molecular Transport      Ardelyx      AstraZeneca      Atezolizumab      Avaprtitinib      Biotech      Blueprint Medicines      Clovis Oncology      COVID-19      Cyxone      Deals      Deciphera Pharmaceuticals      Diagnostics      European Commission      Evox Therapeutics      Fetal and neonatal alloimmune thrombocytopenia      Galapagos      Gastrointestinal Stromal Tumors      Gene Therapy      Gilead Sciences      GlaxoSmithKline      HotSpot Therapeutics      Investing      Joseph Leveque      Life Sciences      Liquidia Technologies      Mammoth Biosciences      Matthew Walsh      Merck      Millicent Pharma      Mirati Therapeutics      ModeRNA      Nautilus Biotechnology      Octant      Oligomerix      Organon      Parkinson's Disease      Paroxysmal nocturnal hemoglobinuria      Pegcetacoplan      Prasterone      Prostate Cancer      Rachel Stahler      Rallybio      Ripretinib      Roche      Rucaparib      Sonya Montgomery      Spinal Muscular Atrophy      SQZ Biotech      Startups      Sunovion Pharmaceuticals      Susan Rodriguez      Sutro Biopharma      SutroVax      Tara Heitner      Tushar Shah      Vaccines      Vaxcyte      Vividion Therapeutics      William Erhardt      Zentalis Pharmaceuticals      Zentera Therapeutics      Zolgensma  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

104714 Patient Navigator - Contract Appointment

MEDICINE/Infectious Diseases Salary commensurate with qualifications and experienceFiling Deadline: Mon 6/15/2020... Read more ...

Regeneron boosts Intellia CRISPR pact with bleeding disorder focus, cash boost

Regeneron boosts Intellia CRISPR pact with bleeding disorder focus, cash boost badams Mon, 06/01/2020 - 07:56 Read more ...

AbbVie pens cancer pact with U.S.-China biotech Jacobio

AbbVie pens cancer pact with U.S.-China biotech Jacobio badams Mon, 06/01/2020 - 07:28 Read more ...

Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the...

Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action badams Mon, 06/01/2020 - 06:40 Read more ...

How a new biotech rule will foster distrust with the public and impede...

In May, federal regulators finalized a new biotechnology policy that will bring sweeping changes to the U.S. food system. Dubbed "SECURE," the rule revises U.S. Department of... Read more ...

FloChiP, a new tool optimizing gene-regulation studies

In the cell, proteins often interact directly with DNA to regulate and influence the expression of genes. For this to happen, proteins need to travel into the cell's nucleus... Read more ...

Researchers control cattle microbiomes to reduce methane and greenhouse gases

Ben-Gurion University of the Negev researchers have learned to control the microbiome of cattle for the first time which could inhibit their methane production, and therefore... Read more ...

Researchers develop biotechnological process for jasmonic acid production

Plants produce the hormone jasmonic acid as a defense response when challenged, making their leaves taste bad to predators. Biologists want to determine whether biological... Read more ...

Gossamer Bio Announces Participation in Upcoming Investor Conferences

SAN DIEGO--- $GOSS-Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease... Read more ...

DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of...

SAN DIEGO, June 1, 2020 /PRNewswire/ - DelMar Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today... Read more ...